📖
Metformin and atorvastatin ameliorate MASH via the AMPK/NF-κB pathway.
Zhang B, Li N, Liu F, Wang G, Chen Q, Sun Y, Yang N, Zhang H, Han J

Metformin and atorvastatin ameliorate MASH via the AMPK/NF-κB pathway.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Front Endocrinol (Lausanne).

Advertisement
SPONSOR CONTENT
Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Metformin and atorvastatin ameliorate MASH via the AMPK/NF-κB pathway.
Author / Organization Zhang B, Li N, Liu F, Wang G, Chen Q, Sun Y, Yang N, Zhang H, Han J
Subject & Discipline Front Endocrinol (Lausanne)
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-120766
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »